NO20013205L - Farmasöytiske formuleringer i hydroksypropylmetylcellulosekapsler - Google Patents

Farmasöytiske formuleringer i hydroksypropylmetylcellulosekapsler

Info

Publication number
NO20013205L
NO20013205L NO20013205A NO20013205A NO20013205L NO 20013205 L NO20013205 L NO 20013205L NO 20013205 A NO20013205 A NO 20013205A NO 20013205 A NO20013205 A NO 20013205A NO 20013205 L NO20013205 L NO 20013205L
Authority
NO
Norway
Prior art keywords
methyl cellulose
pharmaceutical formulations
hydroxypropyl methyl
cellulose capsules
capsules
Prior art date
Application number
NO20013205A
Other languages
English (en)
Other versions
NO20013205D0 (no
NO319712B1 (no
Inventor
Paola Civaroli
Lorena Muggetti
Alessandro Martini
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of NO20013205L publication Critical patent/NO20013205L/no
Publication of NO20013205D0 publication Critical patent/NO20013205D0/no
Publication of NO319712B1 publication Critical patent/NO319712B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20013205A 1999-08-10 2001-06-26 Farmasoytiske formuleringer i hydroksypropylmetylcellulosekapsler NO319712B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9918885.6A GB9918885D0 (en) 1999-08-10 1999-08-10 Pharmaceutical formulations in hydroxypropymethycellulose capsules
PCT/EP2000/006590 WO2001010443A1 (en) 1999-08-10 2000-07-11 Pharmaceutical formulations in hydroxypropylmethylcellulose capsules

Publications (3)

Publication Number Publication Date
NO20013205L true NO20013205L (no) 2001-06-26
NO20013205D0 NO20013205D0 (no) 2001-06-26
NO319712B1 NO319712B1 (no) 2005-09-05

Family

ID=10858930

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013205A NO319712B1 (no) 1999-08-10 2001-06-26 Farmasoytiske formuleringer i hydroksypropylmetylcellulosekapsler

Country Status (18)

Country Link
US (1) US6569452B1 (no)
EP (1) EP1126851B1 (no)
CN (1) CN1245976C (no)
AR (1) AR025060A1 (no)
AT (1) ATE262905T1 (no)
AU (1) AU6158200A (no)
CA (1) CA2354039C (no)
CO (1) CO5200854A1 (no)
CZ (1) CZ293749B6 (no)
DE (1) DE60009442D1 (no)
EA (1) EA200100568A1 (no)
GB (1) GB9918885D0 (no)
HK (1) HK1040930B (no)
HU (1) HUP0104476A3 (no)
IL (2) IL143502A0 (no)
NO (1) NO319712B1 (no)
PE (1) PE20010407A1 (no)
WO (1) WO2001010443A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9925127D0 (en) * 1999-10-22 1999-12-22 Pharmacia & Upjohn Spa Oral formulations for anti-tumor compounds
CN1316970C (zh) * 2002-11-14 2007-05-23 武汉华中科大纳米药业有限公司 一种羟喜树碱固体分散物及其制剂
JP2005183361A (ja) * 2003-10-03 2005-07-07 Ngk Insulators Ltd 電子放出素子、電子放出装置、ディスプレイ及び光源
US20050208146A1 (en) * 2003-10-30 2005-09-22 Pfizer Inc Novel dosage and administration method for oral camptosar
GT200500310A (es) 2004-11-19 2006-06-19 Compuestos organicos
SA06270147B1 (ar) 2005-06-09 2009-12-22 نوفارتيس ايه جي عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين
WO2007033522A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation de gélule contenant de la moxifloxacine et son procédé de préparation
GB0526419D0 (en) * 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
CN101516346B (zh) * 2006-09-26 2012-05-23 株式会社三养社 水不溶性喜树碱衍生物的亚微粒纳米颗粒及其制备方法
CA2844367C (en) * 2011-06-24 2016-02-16 Acenda Pharma, Inc. Method and improved pharmaceutical composition for improving the absorption of an ester prodrug
CN103110605A (zh) * 2011-11-17 2013-05-22 天士力制药集团股份有限公司 一种热熔胶囊制剂及其制备方法
ES2680444T3 (es) * 2014-01-17 2018-09-07 Oncoral Pharma Aps Forma de dosificación oral sólida de irinotecán para el tratamiento del cáncer
CN105287427B (zh) * 2015-10-20 2017-04-19 沈阳红旗制药有限公司 一种利福平半固体胶囊及其制备方法
KR102066402B1 (ko) * 2017-12-22 2020-01-15 대화제약 주식회사 이리노테칸 또는 그의 약제학적으로 허용가능한 염을 포함하는 경구투여용 약제학적 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678516A (en) * 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
DE69531611T2 (de) * 1994-04-28 2004-02-26 Bionumerik Pharmaceuticals, Inc., San Antonio Lactone-stabile camptothecin oder 7 - ethyl camptothecin - formulierung in dimethylisosorbid oder dimethylacetamid
US5597829A (en) 1994-05-09 1997-01-28 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of camptothecin and methods for uses thereof
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
KR20000029784A (ko) * 1996-08-02 2000-05-25 나까도미 히로다카 경구제제용캡슐과경구캡슐제제
AR013261A1 (es) * 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina

Also Published As

Publication number Publication date
CN1245976C (zh) 2006-03-22
HK1040930A1 (en) 2002-06-28
EP1126851B1 (en) 2004-03-31
CZ20012089A3 (cs) 2001-10-17
US6569452B1 (en) 2003-05-27
IL143502A (en) 2006-12-10
CO5200854A1 (es) 2002-09-27
CN1327387A (zh) 2001-12-19
HUP0104476A3 (en) 2004-05-28
IL143502A0 (en) 2002-04-21
ATE262905T1 (de) 2004-04-15
EA200100568A1 (ru) 2001-10-22
AU6158200A (en) 2001-03-05
HUP0104476A2 (hu) 2002-03-28
PE20010407A1 (es) 2001-03-28
EP1126851A1 (en) 2001-08-29
HK1040930B (zh) 2006-10-27
WO2001010443A1 (en) 2001-02-15
AR025060A1 (es) 2002-11-06
DE60009442D1 (de) 2004-05-06
CA2354039C (en) 2008-09-23
CA2354039A1 (en) 2001-02-15
NO20013205D0 (no) 2001-06-26
NO319712B1 (no) 2005-09-05
GB9918885D0 (en) 1999-10-13
CZ293749B6 (cs) 2004-07-14

Similar Documents

Publication Publication Date Title
NO20022970L (no) Hydrogel-drevet medikamentdoseringsform
NO2013004I1 (no) axitinib, valgfritt i form av et farmasøytisk aksentabelt salt
DE69812089D1 (de) Pharmazeutische omeprazol-formulierung
NO20020086L (no) Smaksmaskerte farmasöytiske flytende formuleringer
NO20014035D0 (no) System for oral administrasjon av medikament
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
NO20015670D0 (no) Forbedrede farmasöytiske formuleringer
NO20013205L (no) Farmasöytiske formuleringer i hydroksypropylmetylcellulosekapsler
NO20014738D0 (no) Tolperisonholdig farmasöytisk preparat for oral administrering
NO20015149D0 (no) Nytt farmasöytisk preparat
EE05375B1 (et) LevosimendaniÁfarmatseutilineÁlahus
FR2802423B1 (fr) Compositions pharmaceutiques
NO20015148D0 (no) Nytt farmasöytisk preparat
NO20015104L (no) Nytt farmasöytisk preparat
AR025867A1 (es) Formulacion portasdora farmaceutica
NO20016430D0 (no) Farmasöytisk kompleks
NO20015105L (no) Nytt farmasöytisk preparat
NO20004816D0 (no) Ny farmasøytisk formulering
NO20021036D0 (no) Farmasöytisk preparat
NO20003284D0 (no) Farmasøytisk preparat for oral administrering
ATE235255T1 (de) Tezosentan enthaltende wässerige pharmazeutische zubereitung

Legal Events

Date Code Title Description
RE Reestablishment of rights (par. 72 patents act)
MM1K Lapsed by not paying the annual fees